Induction of fetal/embryonic globin gene expression depends on intact cell signaling in definitive erythroid cells

Amrita Dutta, Shay Karkashon, Radha Raghupathy, Himanshu Bhatia, Lydia Tesfa, Jane A. Little

Research output: Contribution to journalArticle

Abstract

Objective: The induction of fetal hemoglobin during definitive erythropoiesis is a major therapeutic goal in β-globin gene disorders. Butyrate induces fetal hemoglobin, and p38 phosphorylation has been implicated in this process. We studied p38 and the effect of its inhibitors in a physiologic primary cell model of fetal/embryonic globin gene induction during definitive erythropoiesis. Methods: p38 phosphorylation was evaluated in a short-term culture of definitive erythroid precursor (EryD) cells following butyrate induction, absent prolonged exposure to cytokines. The impact of p38 inhibitors on embryonic/fetal globin gene induction by butyrate and on normal erythroid processes, including proliferation, differentiation, cell cycle occupancy, and RNA transcription, was also examined. Results: p38 phosphorylation, maximal at harvest of murine fetal liver-derived EryD (FL EryD), when minimal embryonic/fetal globin gene expression is seen, is suppressed by EPO (as reported by others). Butyrate initially delays EPO-mediated suppression of p38 phosphorylation, but p38 phosphorylation thereafter, at 30. minutes to 48. hours, is equivalent and at low levels in EPO-treated FL EryD, with or without butyrate. Inhibitors of p38, at 10-50 μM, prevent butyrate-mediated induction of embryonic/fetal globin gene expression. We found that p38 inhibitors, which also disrupt non-p38 signaling pathways, perturb cell division, erythroid differentiation, transit through the cell cycle, and RNA transcription in primary EryD. Conclusion: p38 inhibitors interrupt normal erythropoiesis and the capacity for embryonic/fetal globin gene induction. However, p38 signaling is maximal in primary EryD at harvest, when embryonic globin genes are minimally expressed, and diminishes thereafter. We conclude that p38 inhibitors disrupt cellular pathways that are essential to butyrate-induced embryonic/fetal globin gene expression. However, levels of p38 phosphorylation are not coordinate with embryonic/fetal globin gene expression in EryD, and increased signaling through p38 may not be the sine qua non for embryonic/fetal globin gene induction.

Original languageEnglish (US)
Pages (from-to)125-132
Number of pages8
JournalBlood Cells, Molecules, and Diseases
Volume46
Issue number2
DOIs
StatePublished - Feb 15 2011

Fingerprint

Embryonic Induction
Erythroid Cells
Globins
Butyrates
Gene Expression
Phosphorylation
Erythropoiesis
Genes
Fetal Hemoglobin
Cell Cycle
RNA
Erythroid Precursor Cells
Liver
Cell Division

Keywords

  • Butyrate
  • Fetal hemoglobin
  • Hemoglobinopathy
  • P38

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Hematology
  • Cell Biology

Cite this

Induction of fetal/embryonic globin gene expression depends on intact cell signaling in definitive erythroid cells. / Dutta, Amrita; Karkashon, Shay; Raghupathy, Radha; Bhatia, Himanshu; Tesfa, Lydia; Little, Jane A.

In: Blood Cells, Molecules, and Diseases, Vol. 46, No. 2, 15.02.2011, p. 125-132.

Research output: Contribution to journalArticle

Dutta, Amrita ; Karkashon, Shay ; Raghupathy, Radha ; Bhatia, Himanshu ; Tesfa, Lydia ; Little, Jane A. / Induction of fetal/embryonic globin gene expression depends on intact cell signaling in definitive erythroid cells. In: Blood Cells, Molecules, and Diseases. 2011 ; Vol. 46, No. 2. pp. 125-132.
@article{4950196a5f8b4564a52bc830b698e87a,
title = "Induction of fetal/embryonic globin gene expression depends on intact cell signaling in definitive erythroid cells",
abstract = "Objective: The induction of fetal hemoglobin during definitive erythropoiesis is a major therapeutic goal in β-globin gene disorders. Butyrate induces fetal hemoglobin, and p38 phosphorylation has been implicated in this process. We studied p38 and the effect of its inhibitors in a physiologic primary cell model of fetal/embryonic globin gene induction during definitive erythropoiesis. Methods: p38 phosphorylation was evaluated in a short-term culture of definitive erythroid precursor (EryD) cells following butyrate induction, absent prolonged exposure to cytokines. The impact of p38 inhibitors on embryonic/fetal globin gene induction by butyrate and on normal erythroid processes, including proliferation, differentiation, cell cycle occupancy, and RNA transcription, was also examined. Results: p38 phosphorylation, maximal at harvest of murine fetal liver-derived EryD (FL EryD), when minimal embryonic/fetal globin gene expression is seen, is suppressed by EPO (as reported by others). Butyrate initially delays EPO-mediated suppression of p38 phosphorylation, but p38 phosphorylation thereafter, at 30. minutes to 48. hours, is equivalent and at low levels in EPO-treated FL EryD, with or without butyrate. Inhibitors of p38, at 10-50 μM, prevent butyrate-mediated induction of embryonic/fetal globin gene expression. We found that p38 inhibitors, which also disrupt non-p38 signaling pathways, perturb cell division, erythroid differentiation, transit through the cell cycle, and RNA transcription in primary EryD. Conclusion: p38 inhibitors interrupt normal erythropoiesis and the capacity for embryonic/fetal globin gene induction. However, p38 signaling is maximal in primary EryD at harvest, when embryonic globin genes are minimally expressed, and diminishes thereafter. We conclude that p38 inhibitors disrupt cellular pathways that are essential to butyrate-induced embryonic/fetal globin gene expression. However, levels of p38 phosphorylation are not coordinate with embryonic/fetal globin gene expression in EryD, and increased signaling through p38 may not be the sine qua non for embryonic/fetal globin gene induction.",
keywords = "Butyrate, Fetal hemoglobin, Hemoglobinopathy, P38",
author = "Amrita Dutta and Shay Karkashon and Radha Raghupathy and Himanshu Bhatia and Lydia Tesfa and Little, {Jane A.}",
year = "2011",
month = "2",
day = "15",
doi = "10.1016/j.bcmd.2010.10.013",
language = "English (US)",
volume = "46",
pages = "125--132",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Induction of fetal/embryonic globin gene expression depends on intact cell signaling in definitive erythroid cells

AU - Dutta, Amrita

AU - Karkashon, Shay

AU - Raghupathy, Radha

AU - Bhatia, Himanshu

AU - Tesfa, Lydia

AU - Little, Jane A.

PY - 2011/2/15

Y1 - 2011/2/15

N2 - Objective: The induction of fetal hemoglobin during definitive erythropoiesis is a major therapeutic goal in β-globin gene disorders. Butyrate induces fetal hemoglobin, and p38 phosphorylation has been implicated in this process. We studied p38 and the effect of its inhibitors in a physiologic primary cell model of fetal/embryonic globin gene induction during definitive erythropoiesis. Methods: p38 phosphorylation was evaluated in a short-term culture of definitive erythroid precursor (EryD) cells following butyrate induction, absent prolonged exposure to cytokines. The impact of p38 inhibitors on embryonic/fetal globin gene induction by butyrate and on normal erythroid processes, including proliferation, differentiation, cell cycle occupancy, and RNA transcription, was also examined. Results: p38 phosphorylation, maximal at harvest of murine fetal liver-derived EryD (FL EryD), when minimal embryonic/fetal globin gene expression is seen, is suppressed by EPO (as reported by others). Butyrate initially delays EPO-mediated suppression of p38 phosphorylation, but p38 phosphorylation thereafter, at 30. minutes to 48. hours, is equivalent and at low levels in EPO-treated FL EryD, with or without butyrate. Inhibitors of p38, at 10-50 μM, prevent butyrate-mediated induction of embryonic/fetal globin gene expression. We found that p38 inhibitors, which also disrupt non-p38 signaling pathways, perturb cell division, erythroid differentiation, transit through the cell cycle, and RNA transcription in primary EryD. Conclusion: p38 inhibitors interrupt normal erythropoiesis and the capacity for embryonic/fetal globin gene induction. However, p38 signaling is maximal in primary EryD at harvest, when embryonic globin genes are minimally expressed, and diminishes thereafter. We conclude that p38 inhibitors disrupt cellular pathways that are essential to butyrate-induced embryonic/fetal globin gene expression. However, levels of p38 phosphorylation are not coordinate with embryonic/fetal globin gene expression in EryD, and increased signaling through p38 may not be the sine qua non for embryonic/fetal globin gene induction.

AB - Objective: The induction of fetal hemoglobin during definitive erythropoiesis is a major therapeutic goal in β-globin gene disorders. Butyrate induces fetal hemoglobin, and p38 phosphorylation has been implicated in this process. We studied p38 and the effect of its inhibitors in a physiologic primary cell model of fetal/embryonic globin gene induction during definitive erythropoiesis. Methods: p38 phosphorylation was evaluated in a short-term culture of definitive erythroid precursor (EryD) cells following butyrate induction, absent prolonged exposure to cytokines. The impact of p38 inhibitors on embryonic/fetal globin gene induction by butyrate and on normal erythroid processes, including proliferation, differentiation, cell cycle occupancy, and RNA transcription, was also examined. Results: p38 phosphorylation, maximal at harvest of murine fetal liver-derived EryD (FL EryD), when minimal embryonic/fetal globin gene expression is seen, is suppressed by EPO (as reported by others). Butyrate initially delays EPO-mediated suppression of p38 phosphorylation, but p38 phosphorylation thereafter, at 30. minutes to 48. hours, is equivalent and at low levels in EPO-treated FL EryD, with or without butyrate. Inhibitors of p38, at 10-50 μM, prevent butyrate-mediated induction of embryonic/fetal globin gene expression. We found that p38 inhibitors, which also disrupt non-p38 signaling pathways, perturb cell division, erythroid differentiation, transit through the cell cycle, and RNA transcription in primary EryD. Conclusion: p38 inhibitors interrupt normal erythropoiesis and the capacity for embryonic/fetal globin gene induction. However, p38 signaling is maximal in primary EryD at harvest, when embryonic globin genes are minimally expressed, and diminishes thereafter. We conclude that p38 inhibitors disrupt cellular pathways that are essential to butyrate-induced embryonic/fetal globin gene expression. However, levels of p38 phosphorylation are not coordinate with embryonic/fetal globin gene expression in EryD, and increased signaling through p38 may not be the sine qua non for embryonic/fetal globin gene induction.

KW - Butyrate

KW - Fetal hemoglobin

KW - Hemoglobinopathy

KW - P38

UR - http://www.scopus.com/inward/record.url?scp=79151486543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79151486543&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2010.10.013

DO - 10.1016/j.bcmd.2010.10.013

M3 - Article

C2 - 21094617

AN - SCOPUS:79151486543

VL - 46

SP - 125

EP - 132

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 2

ER -